| Trial ID: | L5548 |
| Source ID: | NCT00522470
|
| Associated Drug: |
Rosiglitazone
|
| Title: |
Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Obesity
|
| Interventions: |
DRUG: rosiglitazone
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: Baskent University
|
| Gender: |
FEMALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose:
|
| Start Date: |
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2008-05-09
|
| Locations: |
Baskent University Hospital Department of Endocrinology, Ankara, Bahçelievler, 06490, Turkey
|
| URL: |
https://clinicaltrials.gov/show/NCT00522470
|
